{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T05:40:23Z","timestamp":1687758023270},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T00:00:00Z","timestamp":1350000000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s13277-012-0550-9","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T12:58:54Z","timestamp":1349960334000},"page":"293-299","source":"Crossref","is-referenced-by-count":6,"title":["Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population"],"prefix":"10.1007","volume":"34","author":[{"given":"Benyuan","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lvnan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,12]]},"reference":[{"key":"550_CR1","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.14.4300","volume":"14","author":"AI Gomaa","year":"2008","unstructured":"Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008;14:4300\u20138.","journal-title":"World J Gastroenterol"},{"key":"550_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"550_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/IJGC:34:1:19","volume":"34","author":"MA Heneghan","year":"2003","unstructured":"Heneghan MA, Johnson PJ, Clare M, et al. Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese. Int J Gastrointest Cancer. 2003;34:19\u201326.","journal-title":"Int J Gastrointest Cancer"},{"key":"550_CR4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.20860","volume":"42","author":"N Kato","year":"2005","unstructured":"Kato N, Ji G, Wang Y, et al. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C. Hepatology. 2005;42:846\u201353.","journal-title":"Hepatology"},{"key":"550_CR5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000082089","volume":"48","author":"YJ Kim","year":"2005","unstructured":"Kim YJ, Lee HS. Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Intervirology. 2005;48:10\u20135.","journal-title":"Intervirology"},{"key":"550_CR6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/35003607","volume":"404","author":"A Yang","year":"2000","unstructured":"Yang A, Walker N, Bronson R, et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature. 2000;404:99\u2013103.","journal-title":"Nature"},{"key":"550_CR7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/416560a","volume":"416","author":"ER Flores","year":"2002","unstructured":"Flores ER, Tsai KY, Crowley D, et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature. 2002;416:560\u20134.","journal-title":"Nature"},{"key":"550_CR8","first-page":"1598","volume":"61","author":"XQ Wang","year":"2001","unstructured":"Wang XQ, Ongkeko WM, Lau AW, et al. A possible role of p73 on the modulation of p53 level through MDM2. Cancer Res. 2001;61:1598\u2013603.","journal-title":"Cancer Res"},{"key":"550_CR9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3322\/canjclin.44.3.160","volume":"44","author":"RA Weinberg","year":"1994","unstructured":"Weinberg RA. Oncogenes and tumor suppressor genes. CA Cancer J Clin. 1994;44:160\u201370.","journal-title":"CA Cancer J Clin"},{"key":"550_CR10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/carcin\/21.4.683","volume":"21","author":"YC Cai","year":"2000","unstructured":"Cai YC, Yang GY, Nie Y, et al. Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis. 2000;21:683\u20139.","journal-title":"Carcinogenesis"},{"key":"550_CR11","first-page":"2347","volume":"58","author":"M Mai","year":"1998","unstructured":"Mai M, Yokomizo A, Qian C, et al. Activation of p73 silent allele in lung cancer. Cancer Res. 1998;58:2347\u20139.","journal-title":"Cancer Res"},{"key":"550_CR12","first-page":"1380","volume":"58","author":"S Nomoto","year":"1998","unstructured":"Nomoto S, Haruki N, Kondo M, et al. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res. 1998;58:1380\u20133.","journal-title":"Cancer Res"},{"key":"550_CR13","first-page":"2076","volume":"58","author":"H Takahashi","year":"1998","unstructured":"Takahashi H, Ichimiya S, Nimura Y, et al. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res. 1998;58:2076\u20137.","journal-title":"Cancer Res"},{"key":"550_CR14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/pros.1109","volume":"48","author":"MA Peters","year":"2001","unstructured":"Peters MA, Janer M, Kolb S, et al. Germline mutations in the p73 gene do not predispose to familial prostate-brain cancer. Prostate. 2001;48:292\u20136.","journal-title":"Prostate"},{"key":"550_CR15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2350-5-14","volume":"5","author":"Q Li","year":"2004","unstructured":"Li Q, Athan ES, Wei M, et al. TP73 allelic expression in human brain and allele frequencies in Alzheimer\u2019s disease. BMC Med Genet. 2004;5:14.","journal-title":"BMC Med Genet"},{"key":"550_CR16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0092-8674(00)80540-1","volume":"90","author":"M Kaghad","year":"1997","unstructured":"Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1q36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 1997;90:809\u201319.","journal-title":"Cell"},{"key":"550_CR17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ijc.20746","volume":"114","author":"Z Hu","year":"2005","unstructured":"Hu Z, Miao X, Ma H, et al. Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population. Int J Cancer. 2005;114:455\u201360.","journal-title":"Int J Cancer"},{"key":"550_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3835(02)00041-1","volume":"181","author":"N Hamajima","year":"2002","unstructured":"Hamajima N, Matsuo K, Suzuki T, et al. No association of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphism with the risk of digestive tract cancers in Japanese. Cancer Lett. 2002;181:81\u20135.","journal-title":"Cancer Lett"},{"key":"550_CR19","first-page":"107","volume":"4","author":"A Hiraki","year":"2003","unstructured":"Hiraki A, Matsuo K, Hamajima N, et al. Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes. Asian Pac J Cancer Prev. 2003;4:107\u201312.","journal-title":"Asian Pac J Cancer Prev"},{"key":"550_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02967650","volume":"10","author":"XE Huang","year":"2000","unstructured":"Huang XE, Hamajima N, Katsuda N, et al. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer. 2000;10:307\u201311.","journal-title":"Breast Cancer"},{"key":"550_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.canlet.2004.10.018","volume":"219","author":"Y Niwa","year":"2005","unstructured":"Niwa Y, Hirose K, Matsuo K, et al. Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Cancer Lett. 2005;219:183\u201390.","journal-title":"Cancer Lett"},{"key":"550_CR22","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/carcin\/bgh197","volume":"25","author":"G Li","year":"2004","unstructured":"Li G, Sturgis EM, Wang LE, et al. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004;25:1911\u20136.","journal-title":"Carcinogenesis"},{"key":"550_CR23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/IGC.0b013e3181a130ab","volume":"19","author":"S Kang","year":"2009","unstructured":"Kang S, Wang DJ, Li WS, et al. Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women. Int J Gynecol Cancer. 2009;19:572\u20137.","journal-title":"Int J Gynecol Cancer"},{"key":"550_CR24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/1541-7786.371.2.7","volume":"2","author":"UM Moll","year":"2004","unstructured":"Moll UM, Slade N. p63 and p73: roles in development and tumor formation. Mol Cancer Res. 2004;2:371\u201386.","journal-title":"Mol Cancer Res"},{"key":"550_CR25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.289.5477.304","volume":"289","author":"CD Pozniak","year":"2000","unstructured":"Pozniak CD, Radinovic S, Yang A, et al. An anti-apoptotic role of the p53 family member, p73, during developmental neuron death. Science. 2000;289:304\u20136.","journal-title":"Science"},{"key":"550_CR26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1349-7006.2005.00116.x","volume":"96","author":"T Ozaki","year":"2005","unstructured":"Ozaki T, Nakagawara A. p73, a sophisticated p53 family member in the cancer world. Cancer Sci. 2005;96:729\u201337.","journal-title":"Cancer Sci"},{"key":"550_CR27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/PAI.0b013e3181e9fe58","volume":"18","author":"AT Arfaoui","year":"2010","unstructured":"Arfaoui AT, Ben Mahmoud LK, Ben Hmida A, et al. Relationship between p73 polymorphism and the immunohistochemical profile of the full-length (TAp73) and NH2-truncated (\u0394Np73) isoforms in Tunisian patients. Appl Immunohistochem Mol Morphol. 2010;18:546\u201354.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"550_CR28","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1158\/0008-5472.CAN-04-1804","volume":"64","author":"G Li","year":"2004","unstructured":"Li G, Wang LE, Chamberlain RM, et al. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res. 2004;64:6863\u20136.","journal-title":"Cancer Res"},{"key":"550_CR29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1478-3231.2012.02787.x","volume":"32","author":"X Wang","year":"2012","unstructured":"Wang X, Zhang X, Qiu B, et al. MDM2 SNP309T\u2009>\u2009G polymorphism increases susceptibility to hepatitis B virus-related hepatocellular carcinoma in a northeast Han Chinese population. Liver Int. 2012;32:1172\u20138.","journal-title":"Liver Int"},{"key":"550_CR30","first-page":"271","volume":"18","author":"LM Li","year":"2010","unstructured":"Li LM, Zeng XY, Ji L, et al. Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi. 2010;18:271\u20135.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"550_CR31","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1054\/bjoc.2001.2066","volume":"85","author":"BM Ryan","year":"2001","unstructured":"Ryan BM, McManus R, Daly JS, et al. A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma. Br J Cancer. 2001;85:1499\u2013503.","journal-title":"Br J Cancer"},{"key":"550_CR32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1442-2050.2007.00672.x","volume":"20","author":"H Ge","year":"2007","unstructured":"Ge H, Wang YM, Cao YY, et al. The p73 polymorphisms are not associated with susceptibility to esophageal squamous cell carcinoma in a high incidence region of China. Dis Esophagus. 2007;20:290\u20136.","journal-title":"Dis Esophagus"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-012-0550-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-012-0550-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-012-0550-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T05:21:53Z","timestamp":1687756913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-012-0550-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1007\/s13277-012-0550-9","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,12]]}}}